Daniel G Whitney1, Michelle S Caird2, Karl J Jepsen2, Edward A Hurvitz3, Richard A Hirth4. 1. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, USA. Electronic address: dgwhit@med.umich.edu. 2. Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA. 3. Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, USA. 4. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, USA; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Fractures represent a triple threat to adults with cerebral palsy (CP): common, accumulate early in adulthood, and are consequential to health. An economic evaluation of fractures in CP is needed to highlight priorities for allocating resources to clinical and public health programs aimed at preventing fractures and their disease sequela. OBJECTIVE: To identify short-term healthcare costs associated with fractures among adults with CP. METHODS: A retrospective cohort study was performed using Optum's de-identified Clinformatics® Data Mart Database from 01/01/2011-12/31/2017. The primary cohort included adults ≥ 18 years old with CP with an incident fracture (CP+Fx), and cost estimates were compared with: CP without fractures (CPw/oFx) and without CP+Fx (w/oCP+Fx). A difference-in-difference (DiD) analysis compared the change in pharmacy and medical costs between cohorts from the one-year baseline period through the one-year post-index period in three-month quarters. RESULTS: CP+Fx (n = 855) had higher mean costs in the baseline and follow-up periods compared with CPw/oFx (n = 5667) and w/oCP+Fx (n = 588,042). The first post-index quarter DiD estimate suggests that CP+Fx accumulated an excess $6462 (95%CI = $3810-$9021) compared with w/oCP+Fx and $17,197 (95%CI = $14,418-$19,833) compared with CPw/oFx. The CP+Fx cohort had higher DiD estimates in the other follow-up quarters, but they were not statistically significant compared with CPw/oFx. When stratified by fracture site, vertebral column fractures for CP+Fx vs. w/oCP+Fx accumulated an excess $25,226 (95%CI = $12,639-$37,417). CONCLUSIONS: Fractures, especially of the vertebral column, were associated with high healthcare costs among adults with CP. Studies are needed to identify cost-effective opportunities to utilize available resources to prevent fractures and their costly sequela for CP.
BACKGROUND: Fractures represent a triple threat to adults with cerebral palsy (CP): common, accumulate early in adulthood, and are consequential to health. An economic evaluation of fractures in CP is needed to highlight priorities for allocating resources to clinical and public health programs aimed at preventing fractures and their disease sequela. OBJECTIVE: To identify short-term healthcare costs associated with fractures among adults with CP. METHODS: A retrospective cohort study was performed using Optum's de-identified Clinformatics® Data Mart Database from 01/01/2011-12/31/2017. The primary cohort included adults ≥ 18 years old with CP with an incident fracture (CP+Fx), and cost estimates were compared with: CP without fractures (CPw/oFx) and without CP+Fx (w/oCP+Fx). A difference-in-difference (DiD) analysis compared the change in pharmacy and medical costs between cohorts from the one-year baseline period through the one-year post-index period in three-month quarters. RESULTS: CP+Fx (n = 855) had higher mean costs in the baseline and follow-up periods compared with CPw/oFx (n = 5667) and w/oCP+Fx (n = 588,042). The first post-index quarter DiD estimate suggests that CP+Fx accumulated an excess $6462 (95%CI = $3810-$9021) compared with w/oCP+Fx and $17,197 (95%CI = $14,418-$19,833) compared with CPw/oFx. The CP+Fx cohort had higher DiD estimates in the other follow-up quarters, but they were not statistically significant compared with CPw/oFx. When stratified by fracture site, vertebral column fractures for CP+Fx vs. w/oCP+Fx accumulated an excess $25,226 (95%CI = $12,639-$37,417). CONCLUSIONS: Fractures, especially of the vertebral column, were associated with high healthcare costs among adults with CP. Studies are needed to identify cost-effective opportunities to utilize available resources to prevent fractures and their costly sequela for CP.
Authors: Nalin A Singh; Susan Quine; Lindy M Clemson; Elodie J Williams; Dominique A Williamson; Theodora M Stavrinos; Jodie N Grady; Tania J Perry; Bradley D Lloyd; Emma U R Smith; Maria A Fiatarone Singh Journal: J Am Med Dir Assoc Date: 2011-09-22 Impact factor: 4.669
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: Gemma Tatangelo; Jennifer Watts; Karen Lim; Catherine Connaughton; Julie Abimanyi-Ochom; Fredrik Borgström; Geoff C Nicholson; Catherine Shore-Lorenti; Amanda L Stuart; Sandra Iuliano-Burns; Ego Seeman; Richard Prince; Lyn March; Marita Cross; Tania Winzenberg; Laura L Laslett; Gustavo Duque; Peter R Ebeling; Kerrie M Sanders Journal: J Bone Miner Res Date: 2019-01-07 Impact factor: 6.741
Authors: Richard C Henderson; John A Kairalla; John W Barrington; Almas Abbas; Richard D Stevenson Journal: J Pediatr Date: 2005-06 Impact factor: 4.406
Authors: Setareh A Williams; Shanette G Daigle; Richard Weiss; Yamei Wang; Tarun Arora; Jeffrey R Curtis Journal: Ann Pharmacother Date: 2020-11-04 Impact factor: 3.154
Authors: Daniel G Whitney; Tao Xu; Daniel Whibley; Dayna Ryan; Michelle S Caird; Edward A Hurvitz; Heidi Haapala Journal: J Clin Med Date: 2022-09-22 Impact factor: 4.964